生物标志物 生物标志物
Kittithatch Booncharoen1,2,3, Poosanu Thanapornsangsuth4,5,6, Watayuth Luechaipanit7
1Neurology Center, Phyathai 1 Hospital, Bangkok, Rachathewi, Thailand.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
将FDG-PET模式与血p-tau217结合起来,显著提高了阿尔茨海默病 (AD) 病理学的诊断特异性. 这种整合提高了在认知障碍患者中检测β-粉样蛋白和tau生物标志物的准确性.
科学领域:
- 神经学 神经学
- 放射学 放射学是一门学科.
- 生物标志物发现发现
背景情况:
- FDG-PET是一种长期以来的成像技术,用于评估阿尔茨海默病 (AD) 中的低代谢.
- 这项研究比较了AD患者的生物标志物概况与非AD患者的FDG-PET模式.
- 它探讨了FDG-PET模式与血p-tau217一起用于检测粉样β (Aβ) 和病理的诊断附加值.
研究的目的:
- 研究基于FDG-PET模式的生物标志物配置的差异,用于轻度认知障碍和痴呆症.
- 评估AD FDG-PET模式与血p-tau217在诊断Aβ和tau病理中的互补作用.
- 为了确定组合成像和流体生物标志物的诊断性能.
主要方法:
- 51名患有轻度认知障碍或痴呆症的参与者按FDG-PET模式 (AD与非AD) 分类.
- 测量了Aβ-PET,tau-PET和等离子体生物标志物 (p-tau217,p-tau181,GFAP,NfL).
- ROC分析确定了p-tau217的最佳切割值,并评估了使用FDG-PET模式的诊断性能.
主要成果:
- 与非AD模式相比,AD FDG-PET模式显示Aβ阳性 (A+) 和Aβ/tau阳性 (A+T+) 的比率显著更高.
- 在AD模式组中观察到高Aβ-PET百叶蛋白,tau SUVR和包括p-tau217在内的血生物标志物.
- 单独的血p-tau217显示出优异的诊断性能,并将其与FDG-PET模式相结合,提高了A+T+检测的特异性.
结论:
- FDG-PET模式,特别是与血p-tau217结合使用时,可提高A+和A+T+病理的诊断特异性.
- 整合成像 (FDG-PET) 和液体 (p-tau217) 生物标志物为准确的AD诊断提供了补充价值.
- 这些发现支持一种多式联络方法,以改善阿尔茨海默病的诊断.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516